We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.42%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$19.3B
AUM Growth
+$783M
Cap. Flow
-$455M
Cap. Flow %
-2.35%
Top 10 Hldgs %
20.28%
Holding
1,342
New
146
Increased
332
Reduced
638
Closed
75

Top Buys

Rank Stock Value
1
TJX icon
TJX Companies
TJX
+$37.2M
2
PGR icon
Progressive
PGR
+$34.8M
3
NOC icon
Northrop Grumman
NOC
+$24.6M
4
RVTY icon
Revvity
RVTY
+$24.1M
5
CARR icon
Carrier Global
CARR
+$22.5M

Sector Composition

Rank Sector Weight
1 Technology 22.44%
2 Healthcare 12.4%
3 Financials 11.64%
4 Consumer Discretionary 9.19%
5 Industrials 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HLIO icon
901
Helios Technologies
HLIO
$2.59B
$479K ﹤0.01%
6,145
-165
-3% -$12.1K
IYF icon
902
iShares US Financials ETF
IYF
$4.68B
$479K ﹤0.01%
5,932
LEG icon
903
Leggett & Platt
LEG
$1.5B
$479K ﹤0.01%
9,262
PWB icon
904
Invesco Large Cap Growth ETF
PWB
$2.29B
$479K ﹤0.01%
6,442
SLF icon
905
Sun Life Financial
SLF
$46B
$479K ﹤0.01%
9,310
-1,622
-15% -$85.7K
SYNA icon
906
Synaptics
SYNA
$4.55B
$479K ﹤0.01%
3,085
-1,128
-27% -$152K
WPC icon
907
W.P. Carey
WPC
$17B
$478K ﹤0.01%
+6,547
New +$479K
BOX icon
908
Box
BOX
$4.18B
$474K ﹤0.01%
18,592
+32
+0.2% +$746
TPL icon
909
Texas Pacific Land
TPL
$27.4B
$474K ﹤0.01%
2,673
-4,725
-64% -$823K
CRL icon
910
Charles River Laboratories
CRL
$10.8B
$470K ﹤0.01%
1,272
+441
+53% +$147K
DRNA
911
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$469K ﹤0.01%
12,575
-938
-7% -$28.8K
UI icon
912
Ubiquiti
UI
$32.7B
$468K ﹤0.01%
1,500
HERAU
913
DELISTED
FTAC Hera Acquisition Corp. Units
HERAU
$466K ﹤0.01%
+46,411
New +$465K
FVIV.U
914
DELISTED
Fortress Value Acquisition Corp. IV Units, each consisting of one share of Class A common stock and one-eighth of one redeemable Warrant
FVIV.U
$463K ﹤0.01%
+46,396
New +$465K
SPAQ
915
DELISTED
Spartan Acquisition Corp. III
SPAQ
$461K ﹤0.01%
+47,183
New +$464K
BOH icon
916
Bank of Hawaii
BOH
$3.17B
$459K ﹤0.01%
5,473
-203
-4% -$18.2K
PRO
917
DELISTED
PROS Holdings
PRO
$457K ﹤0.01%
10,029
-290
-3% -$12.8K
FATH
918
DELISTED
Fathom Digital Manufacturing Corporation
FATH
$446K ﹤0.01%
+2,299
New +$451K
AY
919
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$443K ﹤0.01%
11,905
CMRC
920
Commerce.com Inc Series 1
CMRC
$234M
$440K ﹤0.01%
6,787
MWA icon
921
Mueller Water Products
MWA
$3.94B
$440K ﹤0.01%
30,514
CW icon
922
Curtiss-Wright
CW
$27.5B
$434K ﹤0.01%
3,664
+6
+0.2% +$750
ENPH icon
923
Enphase Energy
ENPH
$5.01B
$431K ﹤0.01%
+2,352
New +$345K
AFG icon
924
American Financial Group
AFG
$12B
$430K ﹤0.01%
3,450
NVAX icon
925
Novavax
NVAX
$1.23B
$428K ﹤0.01%
2,019
-1,886
-48% -$346K

Similar funds

Glenmede Trust's Q2 2021 Portfolio in Review

As of Q2 2021, Glenmede Trust held 1,342 positions worth $19.3B, up 4.2% from $18.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Glenmede Trust's Q2 2021 filing shows 146 new, 332 increased, 638 reduced and 75 closed positions. Its largest new stake was Virtu Financial: 627,026 shares worth $17.3M. The largest sale was McKesson, an estimated $82.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q2 2021 buy was Virtu Financial: 627,026 shares worth $17.3M.
  • Glenmede Trust added most to TJX Companies in Q2 2021, an estimated $37.2M increase.
  • Glenmede Trust's biggest Q2 2021 reduction was McKesson, cutting an estimated $82.9M.
  • Glenmede Trust fully exited Western Alliance Bancorporation in Q2 2021, selling an estimated $19.5M.
  • Glenmede Trust's ten largest holdings make up 20% of its $19.3B portfolio in Q2 2021.
  • Glenmede Trust opened 146 new positions and closed 75 in Q2 2021.
  • Glenmede Trust's portfolio value rose 4.2% quarter-over-quarter to $19.3B.

Based on Glenmede Trust's 13F filing for Q2 2021, filed 16 Aug 2021.